{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:27:05Z","timestamp":1790011625265,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd004052","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000}}],"reference-count":170,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004052.pub2","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T11:22:26Z","timestamp":1570792946000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Valproate for acute mania"],"prefix":"10.1002","volume":"2019","author":[{"given":"Janina","family":"Jochim","sequence":"first","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Lane Oxford Oxfordshire UK OX3 7JX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael P","family":"Rifkin-Zybutz","sequence":"additional","affiliation":[{"name":"University of Oxford; University of Oxford Clinical School; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Geddes","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Lane Oxford Oxfordshire UK OX3 7JX"},{"name":"Oxford Health NHS Foundation Trust; Warneford Hospital; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Lane Oxford Oxfordshire UK OX3 7JX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD004052.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cts.12407","article-title":"Endoxifen, a new treatment option for mania: A double-blind, active controlled trial demonstrates the antimanic efficacy of endoxifen","volume":"9","author":"Ahmad","year":"2016","journal-title":"Clinical and Translational Science"},{"issue":"12","key":"10.1002\/14651858.CD004052.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex vs lithium and placebo in the treatment of mania","volume":"271","author":"Bowden","year":"1994","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1520-6394(1997)6:1<26::AID-DA4>3.0.CO;2-3","article-title":"Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania","volume":"6","author":"Bowden","year":"1997","journal-title":"Depression and Anxiety"},{"issue":"6","key":"10.1002\/14651858.CD004052.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/ajp.153.6.765","article-title":"Relation of serum valproate concentration to response in mania","volume":"153","author":"Bowden","year":"1996","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-3223(95)00141-7","article-title":"Plasma GABA predicts acute response to divalproex in mania","volume":"39","author":"Petty","year":"1996","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.1997.01830130041008","article-title":"Depression during mania: treatment response to lithium or divalproex","volume":"54","author":"Swann","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004052.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4088\/JCP.v67n1003","article-title":"A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania","volume":"67","author":"Bowden","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004052.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.chi.0000194567.63289.97","article-title":"A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania","volume":"45","author":"DelBello","year":"2006","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0009|cit9","first-page":"29","article-title":"A naturalistic, single-blind comparison of rapid dose administration of divalproex ER versus quetiapine in patients with acute bipolar mania","volume":"8","author":"Feifel","year":"2011","journal-title":"Innovations in Clinical Neuroscience"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD004052.pub2-BIB0010|cit10","first-page":"13S","article-title":"Dysphoric mania","volume":"12","author":"Clothier","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/ajp.149.1.108","article-title":"A double-blind comparison of valproate and lithium in the treatment of acute mania","volume":"149","author":"Freeman","year":"1992","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004052.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archgenpsychiatry.2011.1508","article-title":"A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents","volume":"69","author":"Geller","year":"2012","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004052.pub2-BIB0013|cit13","first-page":"247","article-title":"Double-blind, randomized, clinical trial of topiramate versus sodium valproate for the treatment of bipolar disorder in adolescents","volume":"25","author":"Hebrani","year":"2009","journal-title":"Pakistan Journal of Medical Sciences"},{"issue":"12","key":"10.1002\/14651858.CD004052.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4088\/JCP.v60n1202","article-title":"Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients","volume":"60","author":"Hirschfeld","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4088\/JCP.08m04960yel","article-title":"A randomized, placebo-controlled, multicentre study of divalproex sodium extended-release in the acute treatment of mania","volume":"71","author":"Hirschfeld","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.eurpsy.2008.12.014","article-title":"Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: A pilot study","volume":"24","author":"Kakkar","year":"2009","journal-title":"European Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/cap.2014.0166","article-title":"Placebo-controlled trial of valproic acid versus risperidone in children 3 - 7 years of age with bipolar I disorder","volume":"25","author":"Kowatch","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0018|cit18","first-page":"1","article-title":"Topiramate versus valproate sodium as adjunctive therapies to a combination of lithium and risperidone for adolescents with bipolar I disorder: Effects on weight and serum lipid profiles","volume":"7","author":"Mahmoudi-Gharaei","year":"2012","journal-title":"Iranian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0019|cit19","first-page":"142","article-title":"A randomised comparison of divalproex loading versus haloperidol in the initial treatment of acute psychotic mania","volume":"57","author":"McElroy","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004052.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4088\/JCP.08m04854yel","article-title":"Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania","volume":"71","author":"McElroy","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004052.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5539\/gjhs.v6n6p163","article-title":"Risperidone versus risperidone plus sodium valproate for treatment of bipolar disorders: A randomized, double-blind clinical-trial","volume":"6","author":"Moosavi","year":"2014","journal-title":"Global Journal of Health Science"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1991.01810250064008","article-title":"Valproate in the treatment of acute mania: A placebo controlled study","volume":"48","author":"Pope","year":"1991","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004052.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/JCP.0b013e31818ce5ba","article-title":"Comparison between lithium and valproate in the treatment of acute mania","volume":"28","author":"Shafti","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD004052.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","article-title":"Olanzapine versus divalproex in the treatment of acute mania","volume":"159","author":"Tohen","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD004052.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4088\/JCP.v69n1113","article-title":"Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study","volume":"69","author":"Tohen","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s002130000380","article-title":"Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder","volume":"150","author":"Vasudev","year":"2000","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD004052.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/CHI.0b013e31819c55ec","article-title":"A double-blind, randomised, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents","volume":"48","author":"Wagner","year":"2009","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0028|cit28","first-page":"1265","article-title":"Olanzapine-valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar mania: A randomized controlled study in a Chinese population group","volume":"11","author":"Xu","year":"2015","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"11","key":"10.1002\/14651858.CD004052.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1176\/appi.ajp.2017.15050657","article-title":"Geri-BD: A randomized double-blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder","volume":"174","author":"Young","year":"2017","journal-title":"American Journal of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD004052.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4088\/JCP.v63n1210","article-title":"A comparison of the efficacy, safety and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder","volume":"63","author":"Zajecka","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004052.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/YIC.0b013e3282fd827c","article-title":"A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode","volume":"23","author":"Bowden","year":"2008","journal-title":"International Clinical Psychopharmacology"},{"issue":"72","key":"10.1002\/14651858.CD004052.pub2-BIB0032|cit32","first-page":"1","article-title":"LICAVAL: combination therapy in acute and maintenance treatment of bipolar disorder","volume":"11","author":"Campos","year":"2010","journal-title":"Trials"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1097\/00004714-199202001-00003","article-title":"Dsyphoric mania","volume":"12","author":"Clothier","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD004052.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0278-5846(92)90025-A","article-title":"Valproate treatment of mania","volume":"16","author":"Emrich","year":"1992","journal-title":"Progress in Neuro-psychopharmacology & Biological Pyschiatry"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0035|cit35","first-page":"S57","article-title":"The prevention of bipolar disorder in genetically at-risk youths","volume":"5","author":"Findling","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD004052.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/YCT.0b013e31824b64b5","article-title":"Comparing efficacy of ECT with and without concurrent sodium valproate therapy in manic patients","volume":"28","author":"Jahangard","year":"2012","journal-title":"Journal of ECT"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/13651500500305622","article-title":"Relationship between serum valproate and lithium levels and efficacy and tolerability in bipolar maintenance therapy","volume":"9","author":"Keck","year":"2005","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"issue":"2","key":"10.1002\/14651858.CD004052.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00004714-200004000-00012","article-title":"Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study","volume":"20","author":"M\u00fcller-Oerlinghausen","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0039|cit39","unstructured":"Novartis Study of licarbazepine in the treatment of manic episodes of bipolar disorder www.novctrd.com"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"593-605","DOI":"10.1111\/j.1399-5618.2010.00850.x","article-title":"Double-blind randomized trial of risperidone versus divalproex in paediatric bipolar disorder","volume":"12","author":"Pavuluri","year":"2010","journal-title":"Bipolar Disorders"},{"issue":"2","key":"10.1002\/14651858.CD004052.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaac.2011.10.019","article-title":"Risperidone and divalproex differentially engage the fronto-striato-temporal circuitry in paediatric mania: A pharmacological functional magnetic resonance imaging study","volume":"51","author":"Pavuluri","year":"2012","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD004052.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"183-93","DOI":"10.1016\/j.jad.2005.01.002","article-title":"Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial","volume":"86","author":"Revicki","year":"2005","journal-title":"Journal of Affective Disorders"},{"issue":"7","key":"10.1002\/14651858.CD004052.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1146-54","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004052.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"213-23","DOI":"10.1111\/j.1399-5618.2004.00115.x","article-title":"Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study","volume":"6","author":"Sachs","year":"2004","journal-title":"Bipolar Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0045|cit45","first-page":"5","article-title":"Comparative study of olanzapine versus divalproex in acute treatment of bipolar disorder : a 3-week prospective study","volume":"17","author":"Sidana","year":"2012","journal-title":"Journal of Mental Health and Human Behavior"},{"issue":"5","key":"10.1002\/14651858.CD004052.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/00048670701261186","article-title":"Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder","volume":"41","author":"Suppes","year":"2007","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD004052.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1008-19","DOI":"10.1016\/j.jaac.2015.09.015","article-title":"Treatment of early-age mania: outcomes for partial and non responders to initial treatment","volume":"54","author":"Walkup","year":"2015","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD004052.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jad.2010.06.013","article-title":"Child mania rating scale-parent version: a valid measure of symptom change due to pharmacotherapy","volume":"128","author":"West","year":"2011","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1002\/14651858.CD004052.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"599-606","DOI":"10.1097\/01.jcp.0000144887.66319.2f","article-title":"Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania","volume":"24","author":"Yatham","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"212-20","DOI":"10.1097\/YIC.0b013e328080ca57","article-title":"A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania","volume":"22","author":"Yatham","year":"2007","journal-title":"International Clinical Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD004052.pub2-BIB0051|cit51","first-page":"49","article-title":"Efficacy of depakine chrono and lithium combination in the treatment of manic states","volume":"103","author":"Aliev","year":"2003","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova."},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004052.pub2-BIB0052|cit52","first-page":"A19; B4","article-title":"Comparative efficacy and tolerability of lithium, carbamazepine and valproate in acute mania","volume":"15","author":"Goswami","year":"2001","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0053|cit53","first-page":"367","article-title":"Utilisation de valpromide en therapeutique psychiatrique","volume":"13","author":"Lambert","year":"1987","journal-title":"Encephale"},{"issue":"8","key":"10.1002\/14651858.CD004052.pub2-BIB0054|cit54","first-page":"335","article-title":"The therapeutic effect of sodium valproate and carbamazepine in mania.","volume":"13","author":"Morinigo","year":"1992","journal-title":"Psiquis"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0055|cit55","first-page":"78","article-title":"Comparative efficacy of preventive use of lithium carbonate, carbamazepine, and sodium valproate in affective and schizoaffective psychoses","volume":"91","author":"Mosolov","year":"1991","journal-title":"Zhurnal Nevropatologii"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0056|cit56","unstructured":"NCT00141505 Solvay Pharmaceuticals: PK effects of bifeprunox and valproate in bipolar I clinicaltrials.gov\/ct2\/show\/NCT00141505"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0057|cit57","first-page":"86","article-title":"Double-blind placebo controlled study of valproate in treating lithium-resistant mania","volume":"21","author":"Tiangin","year":"1995","journal-title":"Chinese Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0058|cit58","unstructured":"NCT01893229 Xu G, Lin K: Comparative efficacy and acceptability of antimanic drugs in acute mania clinicaltrials.gov\/ct2\/show\/NCT01893229"},{"issue":"2","key":"10.1002\/14651858.CD004052.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1176\/appi.ajp.163.2.272","article-title":"Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania.","volume":"163","author":"Allen","journal-title":"American Journal of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD004052.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/mp.2010.101","article-title":"Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys","volume":"16","author":"Alonso","year":"2011","journal-title":"Molecular Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004052.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.4088\/JCP.v67n1009","article-title":"Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study","volume":"67","author":"Altshuler","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD004052.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2165\/00023210-200822070-00002","article-title":"Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal.","volume":"22","author":"Alvarez-Jim\u00e9nez","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0063|cit63","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0064|cit64","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0065|cit65","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0066|cit66","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders - Text Revision (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0067|cit67","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-V)","author":"American Psychiatric Association","year":"2013"},{"issue":"7454","key":"10.1002\/14651858.CD004052.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD004052.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.jcp.0000115665.45074.0d","article-title":"\"Wish bias\" in antidepressant drug trials?","volume":"24","author":"Barbui","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00213-005-0272-4","article-title":"Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder","volume":"184","author":"Bazinet","year":"2006","journal-title":"Psychopharmacology"},{"issue":"112","key":"10.1002\/14651858.CD004052.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"20150670","DOI":"10.1098\/rsif.2015.0670","article-title":"Bipolar disorder dynamics: affective instabilities, relaxation oscillations and noise","volume":"12","author":"Bonsall","year":"2015","journal-title":"Journal of the Royal Society Interface"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.brainresbull.2005.01.004","article-title":"Microarray analysis of rat brain gene expression after chronic administration of sodium valproate","volume":"65","author":"Bosetti","year":"2005","journal-title":"Brain Research Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD004052.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/YIC.0b013e328333ac1b","article-title":"Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial","volume":"25","author":"Bowden","year":"2010","journal-title":"International Clinical Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD004052.pub2-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010236.pub2","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","author":"Bromley","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD004052.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011612.pub2","article-title":"Ketamine and other glutamate receptor modulators for depression in adults","author":"Caddy","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004052.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian network for mood an anxiety treatments (CANMAT) and International society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/eb-2017-102760","article-title":"Heart rate variability in bipolar disorder and borderline personality disorder: a clinical review","volume":"21","author":"Carr","year":"2018","journal-title":"Evidence-based Mental Health"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"479364","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"Journal of Biomedicine & Biotechnology"},{"issue":"16","key":"10.1002\/14651858.CD004052.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"issue":"9799","key":"10.1002\/14651858.CD004052.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"issue":"10047","key":"10.1002\/14651858.CD004052.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","article-title":"Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis","volume":"388","author":"Cipriani","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD004052.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine","volume":"96","author":"Cummings","year":"2011","journal-title":"Journal Arch Dis Child"},{"issue":"12","key":"10.1002\/14651858.CD004052.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1056\/NEJMe048225","article-title":"Clinical trial registration: a atatement from the International Committee of Medical Journal Editors","volume":"351","author":"Angelis","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004052.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.eurpsy.2010.09.011","article-title":"Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice.","volume":"26","author":"De","year":"2011","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0085|cit85","first-page":"6","article-title":"Lithium and valproate in manic and mixed states: a naturalistic prospective study","volume":"20","author":"Grande","year":"2014","journal-title":"Journal of Psychopathology"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/ebmental-2018-300067","article-title":"Advances in our understanding of the genetics of childhood neurodevelopmental disorders","volume":"21","author":"Doherty","year":"2018","journal-title":"Evidence-Based Mental Health"},{"issue":"7","key":"10.1002\/14651858.CD004052.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/bdi.12690","article-title":"Efficacy and tolerability of lithium for the treatment of acute mania in children with bipolar disorder: A systematic review: A report from the ISBD-IGSLi joint task force on lithium treatment","volume":"20","author":"Duffy","year":"2018","journal-title":"Bipolar Disord"},{"issue":"8746","key":"10.1002\/14651858.CD004052.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/0140-6736(91)90201-Y","article-title":"Publication bias in clinical research.","volume":"337","author":"Easterbrook","year":"1991","journal-title":"Lancet"},{"issue":"7109","key":"10.1002\/14651858.CD004052.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Biasin meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00343800","article-title":"Effect of sodium valproate on mania - The GABA-hypothesis of affective disorders","volume":"229","author":"Emrich","year":"1980","journal-title":"Archiv f\u00fcr Psychiatrie und Nervenkrankheiten"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0091|cit91","unstructured":"Food Drug Administration Valproate sodium - Labelling Revision (09\/23\/2015) www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/020593s033lbl.pdf 2015"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","article-title":"Diagnostic criteria for use in psychiatric research","volume":"26","author":"Feighner","year":"1972","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/eb-2018-102912","article-title":"Progress in diagnosis and treatment of bipolar disorder among children and adolescents: an international perspective.","volume":"21","author":"Findling","year":"2018","journal-title":"Evidence-Based Mental Health"},{"issue":"7","key":"10.1002\/14651858.CD004052.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1017\/S1461145711001817","article-title":"Treatment of mixed bipolar states","volume":"15","author":"Fountoulakis","year":"2012","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(00)00299-8","article-title":"The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues","volume":"68","author":"Freeman","year":"2002","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ije\/31.1.72","article-title":"An empirical study of summary effect measures in meta-analyses","volume":"31","author":"Furukawa","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"7-10","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD004052.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S2215-0366(16)30307-8","article-title":"Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies","volume":"3","author":"Furukawa","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD004052.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"e010919","DOI":"10.1136\/bmjopen-2015-010919","article-title":"Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis","volume":"6","author":"Furukawa","year":"2016","journal-title":"BMJ Open"},{"issue":"10010","key":"10.1002\/14651858.CD004052.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"GBD 2013 Risk Factors Collaborators 2015","year":"2015","journal-title":"Lancet"},{"issue":"9878","key":"10.1002\/14651858.CD004052.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD004052.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/wps.20246","article-title":"Time to abandon placebo control in pivotal phase III trials?","volume":"14","author":"Geddes","year":"2015","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00535-006-1961-4","article-title":"Valproic acid-induced pancreatitis: 16 new cases and a review of the literature","volume":"42","author":"Gerstner","year":"2007","journal-title":"Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD004052.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0004867418816813","article-title":"Challenges in identifying behavioural markers of bipolar disorder through objective smartphone data","volume":"53","author":"Goodday","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004052.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0106|cit106","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"10027","key":"10.1002\/14651858.CD004052.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jpsychires.2004.10.007","article-title":"Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients","volume":"39","author":"Hahn","year":"2005","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/nyas.13048","article-title":"Innovative approaches to bipolar disorder and its treatment","volume":"1366","author":"Harrison","year":"2016","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/YCO.0b013e328353d467","article-title":"Acute treatment of mania in children and adolescents","volume":"25","author":"Hazell","year":"2012","journal-title":"Current Opinion in Psychiatry"},{"issue":"7414","key":"10.1002\/14651858.CD004052.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0112|cit112","unstructured":"Higgins JP Deeks JJ editor(s) Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0113|cit113","unstructured":"Higgins JP Altman DG Sterne JA editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"283-7","DOI":"10.1016\/j.jad.2013.10.054","article-title":"Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011","volume":"155","author":"Hooshmand","year":"2014","journal-title":"Journal of Affective Disorders"},{"issue":"2-3","key":"10.1002\/14651858.CD004052.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: A commentatory","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochemistry International"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0116|cit116","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2015"},{"issue":"12","key":"10.1002\/14651858.CD004052.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archpsyc.62.12.1322","article-title":"Psychosocial disability in the course of bipolar I and bipolar II disorders: a prospective comparative, longitudinal study","volume":"62","author":"Judd","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jad.2016.01.043","article-title":"Changes in mood stabilizer prescription patterns in bipolar disorder","volume":"195","author":"Karanti","year":"2016","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"g5673","DOI":"10.1136\/bmj.g5673","article-title":"Assessment and management of bipolar disorder: summary of updated NICE guidance","volume":"349","author":"Kendall","year":"2014","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0120|cit120","first-page":"64","article-title":"Psychopharmacological treatment of 1650 in-patients with acute mania-data from the AMSP study.","volume":"191","author":"Kleimann","year":"2016","journal-title":"Journal of Affective Disorders"},{"issue":"5","key":"10.1002\/14651858.CD004052.pub2-BIB0121|cit121","first-page":"707","article-title":"Neuropsychotropic action of a new antiepileptic: depramide","volume":"1","author":"Lambert","year":"1966","journal-title":"Annales Medico-Psychologiques"},{"issue":"1-3","key":"10.1002\/14651858.CD004052.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2011.06.008","article-title":"Life expectancy among persons with schizophrenia or bipolar affective disorder","volume":"131","author":"Laursen","year":"2011","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0123|cit123","first-page":"5","article-title":"Women and bipolar disorder: An update","volume":"64","author":"Leibenluft","year":"2000","journal-title":"Bulletin of the Menninger Clinic"},{"issue":"3","key":"10.1002\/14651858.CD004052.pub2-BIB0124|cit124","first-page":"74","article-title":"Anticonvulsant use in the treatment of bipolar disorder: a primer for primary care physicians","volume":"1","author":"Leo","year":"1999","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"issue":"1-3","key":"10.1002\/14651858.CD004052.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(00)00361-X","article-title":"Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: Are they relevant for the treatment and course of bipolar disorders?","volume":"69","author":"Li","year":"2002","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"66-8","DOI":"10.1034\/j.1399-5618.4.s1.27.x","article-title":"Limits of the applicability and generalizability of drug trials in mania","volume":"4 Suppl 1","author":"Licht","year":"2002","journal-title":"Bipolar Disorder"},{"issue":"12","key":"10.1002\/14651858.CD004052.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0004867415617657","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"49","author":"Malhi","year":"2015","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/9781118936979.ch51","article-title":"Valproate","volume-title":"The Treatment of Epilepsy","author":"Marson","year":"2015"},{"issue":"9","key":"10.1002\/14651858.CD004052.pub2-BIB0129|cit129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011611","article-title":"Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults","author":"McCloud","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD004052.pub2-BIB0130|cit130","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004048.pub4","article-title":"Lithium for acute mania","author":"McKnight","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","article-title":"Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts.","volume":"81","author":"Meador","year":"2008","journal-title":"Epilepsy Research"},{"issue":"3","key":"10.1002\/14651858.CD004052.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0133|cit133","unstructured":"Drug Safety Update -MHRA https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/701831\/DSU-April-2018-PDF.pdf April 2018"},{"issue":"5","key":"10.1002\/14651858.CD004052.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"339","author":"Moher","year":"2009","journal-title":"BJM"},{"issue":"2","key":"10.1002\/14651858.CD004052.pub2-BIB0136|cit136","first-page":"193","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/eb-2017-102701","article-title":"The limitations of using randomised controlled trials as a basis for developing treatment guidelines","volume":"21","author":"Mulder","year":"2018","journal-title":"Evidence-Based Mental Health"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"44-8","DOI":"10.1016\/j.seizure.2016.01.019","article-title":"Prescribing trends for sodium valproate in Ireland","volume":"36","author":"Murphy","year":"2016","journal-title":"Seizure"},{"issue":"15","key":"10.1002\/14651858.CD004052.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clinical Biochemistry"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0140|cit140","unstructured":"National Institute for Health and Care Excellence (NICE) Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care (updated edition) (CG185) National Collaborating Centre for Mental Health; The British Psychological Society & The Royal College of Psychiatrists 2014"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0141|cit141","unstructured":"Ntional Institute for Health and Care Excellence (NICE) Bipolar disorder: assessment and management; Clinical guideline [CG185] www.nice.org.uk\/guidance\/cg185\/chapter\/1-Recommendations#managing-mania-or-hypomania-in-adults-in-secondary-care-2) April 2018"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0142|cit142","unstructured":"National Collaborating Centre for Mental Health Antenatal and postnatal mental health (National clinical guideline 192) www.nice.org.uk\/guidance\/cg192\/evidence\/full-guideline-pdf-4840896925 2018"},{"issue":"10","key":"10.1002\/14651858.CD004052.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: A summary of 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"issue":"9878","key":"10.1002\/14651858.CD004052.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1663-71","DOI":"10.1016\/S0140-6736(13)60989-7","article-title":"Bipolar disorder diagnosis: challenges and future directions","volume":"381","author":"Phillips","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004052.pub2-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"573-84","DOI":"10.1111\/j.1399-5618.2012.01042.x","article-title":"Evidence-based options for treatment-resistant adult bipolar disorder patients","volume":"14","author":"Poon","year":"2012","journal-title":"Bipolar Disorders"},{"issue":"11","key":"10.1002\/14651858.CD004052.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1528-1157.1999.tb02029.x","article-title":"The pharmacologic basis of antiepileptic drug action","volume":"40","author":"Rho","year":"1999","journal-title":"Epilepsia"},{"issue":"16","key":"10.1002\/14651858.CD004052.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","article-title":"The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?","volume":"64","author":"Rosenberg","year":"2007","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/2046-4053-3-107.","article-title":"Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosis","volume":"3","author":"Selph","year":"2014","journal-title":"Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD004052.pub2-BIB0149|cit149","doi-asserted-by":"publisher","first-page":"1359-66","DOI":"10.1177\/0956797611417632","article-title":"False-positive psychology: undisclosed flexibility in data collection and analysis allows presenting anything as significant","volume":"22","author":"Simmons","year":"2011","journal-title":"Psychological Science"},{"issue":"6","key":"10.1002\/14651858.CD004052.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archpsyc.1978.01770300115013","article-title":"Research diagnostic criteria: rationale and reliability","volume":"35","author":"Spitzer","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD004052.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2000","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0152|cit152","unstructured":"Sterne JA Egger M Moher D Boutron I editor(s) Chapter 10: Addressing reporting biases. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.1997.01830130041008","article-title":"Depression during mania: treatment response to lithium or divalproex","volume":"54","author":"Swann","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004052.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-5618.2007.00357.x","article-title":"Manic symptoms and impulsivity during bipolar depressive episodes","volume":"9","author":"Swann","year":"2007","journal-title":"Bipolar Disorders"},{"issue":"3","key":"10.1002\/14651858.CD004052.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1600-0404.2003.00253.x","article-title":"Valproic acid blood genomic expression patterns in children with epilepsy - a pilot study","volume":"109","author":"Tang","year":"2004","journal-title":"Acta Neurologica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD004052.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1017\/S003329170600715X","article-title":"Seven criteria for improving effectiveness trials in psychiatry","volume":"36","author":"Tansella","year":"2006","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0157|cit157","volume-title":"The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust Prescribing Guidelines","author":"Taylor","year":"2009"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4292\/wjgpt.v8.i1.26","article-title":"Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity","volume":"8","author":"Telles-Correia","year":"2017","journal-title":"World Journal of Gastrointestinal Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1136\/ebmental-2018-300040","article-title":"Twenty years of progress in paediatric psychopharmacology: accomplishments and unmet needs","volume":"21","author":"Vitiello","year":"2018","journal-title":"Evid Based Ment Health"},{"issue":"3","key":"10.1002\/14651858.CD004052.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/comp.2001.23143","article-title":"Self-reported quality of life across mood states in bipolar disorder","volume":"42","author":"Vojta","year":"2001","journal-title":"Comprehensive Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004052.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/eb-2016-102491","article-title":"Designing and analysing clinical trials in mental health: an evidence synthesis approach","volume":"19","author":"Wandel","year":"2016","journal-title":"Evidence-Based Mental Health"},{"issue":"7","key":"10.1002\/14651858.CD004052.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0006-3223(95)00611-7","article-title":"Enhanced protein kinase C activity and translocation in bipolar affective disorder brains","volume":"40","author":"Wang","year":"1996","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004052.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3956(98)90057-7","article-title":"Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients","volume":"33","author":"Wang","year":"1999","journal-title":"Journal of Psychiatric Research"},{"issue":"5","key":"10.1002\/14651858.CD004052.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-3223(01)01147-7","article-title":"Increased association of brain protein kinase C with the receptor for activated C kinase-1 (RACK1) in bipolar affective disorder","volume":"50","author":"Wang","year":"2001","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0165|cit165","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organization","year":"1992"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/eb-2017-102718","article-title":"A systematic review of network meta-analyses for pharmacological treatment of common mental disorders","volume":"21","author":"Williams","year":"2018","journal-title":"Evidence-Based Mental Health"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0167|cit167","volume-title":"Bipolar Disorder: A Clinician's Guide to Biological Treatments","author":"Yatham","year":"2002"},{"issue":"2","key":"10.1002\/14651858.CD004052.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials","volume":"36","author":"Yildiz","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD004052.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0033291714001305","article-title":"A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania","volume":"45","author":"Yildiz","year":"2015","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004052.pub2-BIB0170|cit170","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004052","article-title":"Valproate for acute mood episodes in bipolar disorder","author":"Macritchie","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004052.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T12:09:45Z","timestamp":1690546185000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004052.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":170,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004052.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,7]]}}}